Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 79

1.

Bilateral inferior hemifield visual loss secondary to a pituitary prolactinoma.

Batra R, Toogood A, Jacks AS.

Can J Ophthalmol. 2017 Dec;52(6):e220-e225. doi: 10.1016/j.jcjo.2017.05.005. Epub 2017 Jul 18. No abstract available.

PMID:
29217048
2.

The screening and management of pituitary dysfunction following traumatic brain injury in adults: British Neurotrauma Group guidance.

Tan CL, Alavi SA, Baldeweg SE, Belli A, Carson A, Feeney C, Goldstone AP, Greenwood R, Menon DK, Simpson HL, Toogood AA, Gurnell M, Hutchinson PJ.

J Neurol Neurosurg Psychiatry. 2017 Nov;88(11):971-981. doi: 10.1136/jnnp-2016-315500. Epub 2017 Aug 31. Review.

3.

KLB, encoding β-Klotho, is mutated in patients with congenital hypogonadotropic hypogonadism.

Xu C, Messina A, Somm E, Miraoui H, Kinnunen T, Acierno J Jr, Niederländer NJ, Bouilly J, Dwyer AA, Sidis Y, Cassatella D, Sykiotis GP, Quinton R, De Geyter C, Dirlewanger M, Schwitzgebel V, Cole TR, Toogood AA, Kirk JM, Plummer L, Albrecht U, Crowley WF Jr, Mohammadi M, Tena-Sempere M, Prevot V, Pitteloud N.

EMBO Mol Med. 2017 Oct;9(10):1379-1397. doi: 10.15252/emmm.201607376.

4.

Prolactinomas diagnosed in the postmenopausal period: Clinical phenotype and outcomes.

Santharam S, Tampourlou M, Arlt W, Ayuk J, Gittoes N, Toogood A, Webster R, Karavitaki N.

Clin Endocrinol (Oxf). 2017 Nov;87(5):508-514. doi: 10.1111/cen.13399. Epub 2017 Jul 18.

PMID:
28626987
5.

Outcome of Nonfunctioning Pituitary Adenomas That Regrow After Primary Treatment: A Study From Two Large UK Centers.

Tampourlou M, Ntali G, Ahmed S, Arlt W, Ayuk J, Byrne JV, Chavda S, Cudlip S, Gittoes N, Grossman A, Mitchell R, O'Reilly MW, Paluzzi A, Toogood A, Wass JAH, Karavitaki N.

J Clin Endocrinol Metab. 2017 Jun 1;102(6):1889-1897. doi: 10.1210/jc.2016-4061.

PMID:
28323946
6.

Social, educational and vocational outcomes in patients with childhood-onset and young-adult-onset growth hormone deficiency.

Mitra MT, Jönsson P, Åkerblad AC, Clayton P, Kołtowska-Häggström M, Korbonits M, Toogood A, Gleeson H.

Clin Endocrinol (Oxf). 2017 Apr;86(4):526-533. doi: 10.1111/cen.13291. Epub 2017 Feb 3.

PMID:
27978600
7.

Vitamin D Deficiency in Traumatic Brain Injury and Its Relationship with Severity of Injury and Quality of Life: A Prospective, Observational Study.

Toman E, Bishop JR, Davies DJ, Su Z, Criseno S, Mason A, Toogood AA, Belli A.

J Neurotrauma. 2017 Apr 1;34(7):1448-1456. doi: 10.1089/neu.2016.4494. Epub 2016 Dec 20.

PMID:
27825289
8.

A Follow-Up Study of the Prevalence of Valvular Heart Abnormalities in Hyperprolactinemic Patients Treated With Cabergoline.

Drake WM, Stiles CE, Bevan JS, Karavitaki N, Trainer PJ, Rees DA, Richardson TI, Baldeweg SE, Stojanovic N, Murray RD, Toogood AA, Martin NM, Vaidya B, Han TS, Steeds RP; UK Cabergoline valvulopathy study group, Baldeweg FC, Sheikh UE, Kyriakakis N, Parasuraman SK, Taylor L, Butt N, Anyiam S.

J Clin Endocrinol Metab. 2016 Nov;101(11):4189-4194. Epub 2016 Aug 29.

PMID:
27571182
9.

Management of glucocorticoid replacement in adrenal insufficiency shows notable heterogeneity - data from the EU-AIR.

Murray RD, Ekman B, Uddin S, Marelli C, Quinkler M, Zelissen PM; the EU-AIR Investigators.

Clin Endocrinol (Oxf). 2017 Mar;86(3):340-346. doi: 10.1111/cen.13267. Epub 2016 Dec 5.

10.

Recommendations for Premature Ovarian Insufficiency Surveillance for Female Survivors of Childhood, Adolescent, and Young Adult Cancer: A Report From the International Late Effects of Childhood Cancer Guideline Harmonization Group in Collaboration With the PanCareSurFup Consortium.

van Dorp W, Mulder RL, Kremer LC, Hudson MM, van den Heuvel-Eibrink MM, van den Berg MH, Levine JM, van Dulmen-den Broeder E, di Iorgi N, Albanese A, Armenian SH, Bhatia S, Constine LS, Corrias A, Deans R, Dirksen U, Gracia CR, Hjorth L, Kroon L, Lambalk CB, Landier W, Levitt G, Leiper A, Meacham L, Mussa A, Neggers SJ, Oeffinger KC, Revelli A, van Santen HM, Skinner R, Toogood A, Wallace WH, Haupt R.

J Clin Oncol. 2016 Oct 1;34(28):3440-50. doi: 10.1200/JCO.2015.64.3288. Epub 2016 Jul 25. Review.

11.

ACTH and gonadotropin deficiencies predict mortality in patients treated for nonfunctioning pituitary adenoma: long-term follow-up of 519 patients in two large European centres.

O'Reilly MW, Reulen RC, Gupta S, Thompson CA, Dineen R, Goulden EL, Bugg G, Pearce H, Toogood AA, Gittoes NJ, Mitchell R, Thompson CJ, Ayuk J.

Clin Endocrinol (Oxf). 2016 Nov;85(5):748-756. doi: 10.1111/cen.13141. Epub 2016 Jul 25.

12.

Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol.

Woods CP, Argese N, Chapman M, Boot C, Webster R, Dabhi V, Grossman AB, Toogood AA, Arlt W, Stewart PM, Crowley RK, Tomlinson JW.

Eur J Endocrinol. 2015 Nov;173(5):633-42. doi: 10.1530/EJE-15-0608. Epub 2015 Aug 20.

13.

The modulation of corticosteroid metabolism by hydrocortisone therapy in patients with hypopituitarism increases tissue glucocorticoid exposure.

Sherlock M, Behan LA, Hannon MJ, Alonso AA, Thompson CJ, Murray RD, Crabtree N, Hughes BA, Arlt W, Agha A, Toogood AA, Stewart PM.

Eur J Endocrinol. 2015 Nov;173(5):583-93. doi: 10.1530/EJE-15-0490. Epub 2015 Aug 11.

14.

Effect of cancer treatment on hypothalamic-pituitary function.

Crowne E, Gleeson H, Benghiat H, Sanghera P, Toogood A.

Lancet Diabetes Endocrinol. 2015 Jul;3(7):568-76. doi: 10.1016/S2213-8587(15)00008-X. Epub 2015 Apr 12. Review.

PMID:
25873572
15.

Extensive experience in the management of macroprolactinomas.

Green AI, Sherlock M, Stewart PM, Gittoes NJ, Toogood AA.

Clin Endocrinol (Oxf). 2014 Jul;81(1):85-92. doi: 10.1111/cen.12418. Epub 2014 Mar 13.

PMID:
24483350
16.

A cross-sectional study of the prevalence of cardiac valvular abnormalities in hyperprolactinemic patients treated with ergot-derived dopamine agonists.

Drake WM, Stiles CE, Howlett TA, Toogood AA, Bevan JS, Steeds RP; UK Dopamine Agonist Valvulopathy Group.

J Clin Endocrinol Metab. 2014 Jan;99(1):90-6. doi: 10.1210/jc.2013-2254. Epub 2013 Dec 20.

17.

Response to GH treatment in adult GH deficiency is predicted by gender, age, and IGF1 SDS but not by stimulated GH-peak.

Feldt-Rasmussen U, Brabant G, Maiter D, Jonsson B, Toogood A, Koltowska-Haggstrom M, Rasmussen AK, Buchfelder M, Saller B, Biller BM.

Eur J Endocrinol. 2013 Apr 15;168(5):733-43. doi: 10.1530/EJE-13-0005. Print 2013 May.

18.

Outcome of Cushing's disease following transsphenoidal surgery in a single center over 20 years.

Hassan-Smith ZK, Sherlock M, Reulen RC, Arlt W, Ayuk J, Toogood AA, Cooper MS, Johnson AP, Stewart PM.

J Clin Endocrinol Metab. 2012 Apr;97(4):1194-201. doi: 10.1210/jc.2011-2957. Epub 2012 Jan 25.

PMID:
22278423
19.

Similar clinical features among patients with severe adult growth hormone deficiency diagnosed with insulin tolerance test or arginine or glucagon stimulation tests.

Toogood A, Brabant G, Maiter D, Jonsson B, Feldt-Rasmussen U, Koltowska-Haggstrom M, Rasmussen AK, Buchfelder M, Saller B, Biller BM.

Endocr Pract. 2012 May-Jun;18(3):325-34. doi: 10.4158/EP11146.OR.

PMID:
22068248
20.

Health care use of long-term survivors of childhood cancer: the British Childhood Cancer Survivor Study.

Rebholz CE, Reulen RC, Toogood AA, Frobisher C, Lancashire ER, Winter DL, Kuehni CE, Hawkins MM.

J Clin Oncol. 2011 Nov 1;29(31):4181-8. doi: 10.1200/JCO.2011.36.5619. Epub 2011 Sep 26.

PMID:
21947833

Supplemental Content

Loading ...
Support Center